Paeonol prevents IL-1β-induced inflammatory response and degradation of type II collagen in human primary chondrocytes
Source abstract
Abstract
Osteoarthritis (OA) is a common joint disease for which a safe and reliable treatment has yet to be developed. Here, we demonstrated the potential benefit of treatment with paeonol, a derivative of Paeonia suffruticosa, in the treatment and prevention of OA. Chondrogenic cell line ATDC5 cells were cultured with IL-1β and the effects of paeonol were assessed through qRT-PCR, western blot analysis, MTT, ELISA, and NF-κB luciferase reporter gene assay. Our findings demonstrate a novel ability of paeonol to inhibit numerous factors of OA, including expressions of IL-6, TNF-α, NOX2, PTGS2, NUCB2/nesfatin-1, ICAM-1, VCAM-1, MMP-3/13, degradation of type II collagen, and NF-κB activation through the rescue of IκBα. Additionally, we assessed the effects of paeonol on cell viability to confirm its safety. These findings implicate a valuable potential role of paeonol in the treatment and prevention of OA.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Inflammatory mediators and NSAID effects · NF-κB Signaling Pathways
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics, No. 89 hospital of Chinese People’s Liberation Army
Department of hand and foot orthopedic, Weifang People’s Hospital
Department of Neurology, Chinese Medicine Hospital of Rizhao City
References (39)
Show source-provided references
1. 10.1016/j.joca.2015.02.70110.1016/j.joca.2015.02.701 ↗
2. 10.1093/rheumatology/ker13410.1093/rheumatology/ker134 ↗
3. 10.1038/nrrheum.2010.19610.1038/nrrheum.2010.196 ↗
4. 10.1016/B978-0-12-809847-9.00002-710.1016/B978-0-12-809847-9.00002-7 ↗
5. 10.1155/2014/17928410.1155/2014/179284 ↗
6. 10.1002/jor.2257710.1002/jor.22577 ↗
7. 10.1007/s00441-016-2551-210.1007/s00441-016-2551-2 ↗
8. 10.1016/j.actbio.2015.11.04310.1016/j.actbio.2015.11.043 ↗
9. 10.1097/j.pain.000000000000056210.1097/j.pain.0000000000000562 ↗
10. 10.1002/jor.2258510.1002/jor.22585 ↗
11. 10.1007/s00109-016-1418-z10.1007/s00109-016-1418-z ↗
12. 10.1007/s10753-015-0206-110.1007/s10753-015-0206-1 ↗
13. 10.1016/j.joca.2018.02.27010.1016/j.joca.2018.02.270 ↗
14. 10.1038/cddis.2017.52210.1038/cddis.2017.522 ↗
15. 10.1002/art.2475710.1002/art.24757 ↗
16. 10.1093/rheumatology/kev10610.1093/rheumatology/kev106 ↗
17. Karatay S, Kiziltunc A, Yildirim K, et al. Effects of different hyaluronic acid products on synovial fluid levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in knee osteoarthritis. Ann Clin Lab Sci. 2004;34:330–335.
18. 10.18632/aging.10132810.18632/aging.101328 ↗
19. 10.1172/JCI9514710.1172/JCI95147 ↗
20. 10.1016/j.joca.2006.04.00810.1016/j.joca.2006.04.008 ↗
21. 10.1136/rmdopen-2015-00006110.1136/rmdopen-2015-000061 ↗
22. 10.1073/pnas.160348811310.1073/pnas.1603488113 ↗
23. 10.1016/j.biocel.2013.08.01810.1016/j.biocel.2013.08.018 ↗
24. 10.1007/s10787-017-0385-510.1007/s10787-017-0385-5 ↗
25. 10.1002/art.2452210.1002/art.24522 ↗
26. 10.3109/21691401.2016.116091810.3109/21691401.2016.1160918 ↗
27. 10.1080/21691401.2019.159142710.1080/21691401.2019.1591427 ↗
28. 10.1007/s12192-018-0888-z10.1007/s12192-018-0888-z ↗
29. 10.1016/j.ejphar.2019.01.00810.1016/j.ejphar.2019.01.008 ↗
30. 10.1136/ard.2004.02527010.1136/ard.2004.025270 ↗
31. 10.1038/nrrheum.2016.13610.1038/nrrheum.2016.136 ↗
32. 10.1007/978-981-10-8022-7_7310.1007/978-981-10-8022-7_73 ↗
33. 10.1016/j.bcp.2007.01.00510.1016/j.bcp.2007.01.005 ↗
34. Ehrich EW, Schnitzer TJ, McIlwain H, Rofecoxib Osteoarthritis Pilot Study Group, et al. Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. J Rheumatol. 1999;26:2438–2447.
35. Cremers NAJ, Koenders MI, van de Loo FAJ, et al. The role of NOX2-derived reactive oxygen species in collagenase-induced osteoarthritis. Osteoarthr Cartil. 2018;30:1e11.
36. 10.1136/annrheumdis-2013-eular.115710.1136/annrheumdis-2013-eular.1157 ↗
37. Ji B, Guo W, Ma H, et al. Isoliquiritigenin suppresses IL-1β induced apoptosis and inflammation in chondrocyte-like ATDC5 cells by inhibiting NF-κB and exerts chondroprotective effects on a mouse model of anterior cruciate ligament transection. Int J Mol Med. 2017;40:1709–1718.
38. 10.1186/s13075-017-1426-610.1186/s13075-017-1426-6 ↗
39. 10.1007/s10753-017-0611-810.1007/s10753-017-0611-8 ↗